GLP-1 agonist therapy (Poolbeg Pharma)

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameGLP-1 agonist therapy (Poolbeg Pharma)
Drug Alias NameOral Encapsulated GLP-1R Agonist therapy (Poolbeg Pharma)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPoolbeg Pharma PLCAnabio R&D Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnabio R&D Co LtdPoolbeg Pharma PLC
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A